INSM · NASDAQ · STOCK
Insmed Incorporated
$132.61
52W $90.39 – $212.75
56/100
$28.73B
-32.3
0.79
Is INSM Bullish or Bearish?
Mixed.
Innellis AI committee rates Insmed Incorporated (INSM) Watch with a composite score of 56/100
, based on 6 analysts with 33% agreement.
Last updated August 11, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +4.08 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -15.92 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Growth Analyst sees a compelling case — revenue growing 185.8% yoy -- genuine top-line momentum. Value Analyst remains cautious — price-to-book of 50.2x prices in significant intangible value. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- Revenue growing 185.8% YoY -- genuine top-line momentum — Growth
- MACD histogram positive -- bullish momentum — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- Price-to-book of 50.2x prices in significant intangible value — Value
- ROE of only -111.3% -- cheap may mean cheap for a reason — Value
- RSI at 79 is in overbought territory — Technical
- Bollinger bandwidth of 44.4% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 11, 2026
Overall Committee Score
56/100
Agreement
33%
Analysts
6
Conviction
Contested
Sector Rank
Top 76%
of 192 Healthcare peers
Value Analyst
bearish
30
/ 100 · Moderate confidence
Multiples don't clear a genuine value bar here, or cheapness looks justified by weak fundamentals
− Price-to-book of 50.2x prices in significant intangible value
Growth Analyst
bullish
85
/ 100 · Low confidence
Strong, accelerating growth with consistent execution
+ Revenue growing 185.8% YoY -- genuine top-line momentum
Technical Analyst
neutral
48
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
− RSI at 79 is in overbought territory
Risk Analyst
bearish
35
/ 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 44.4% signals elevated volatility
Macro Analyst
bullish
78
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst
neutral
60
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager
neutral
55
/ 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 2 existing position pair(s) are highly correlated already
Technical Analysis
RSI (14)
78.9
Overbought
MACD Histogram
3.662
Bullish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Lh Ll
Support
$90.42
Resistance
$166.19
Bollinger %B
0.96
Inside Bands
Price vs Moving Averages
EMA 9
$119.94
Above
EMA 21
$113.16
Above
EMA 50
$112.02
Above
EMA 200
$127.26
Above
Fundamental Analysis
Valuation
67
Profitability
25
Financial Health
100
Cash Flow
15
Valuation
P/E Ratio
-32.3×
P/B Ratio
38.04×
PEG Ratio
-1.28
Dividend Yield
0.00%
52W High
$212.75
52W Low
$90.39
Quality & Growth
ROE
-17277.6%
ROA
-5638.1%
Gross Margin
8327.2%
Operating Margin
-7186.3%
Revenue Growth YoY
—
Debt / Equity
0.05
AI Fundamental Assessment
[reduced confidence: limited earnings history] P/E ratio of -32.3 (inexpensive relative to a 15-40x range); Price-to-book of 38.0x; PEG ratio of -1.3 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -172.8%; Return on assets of -56.4%; Net margin of -76.9%; Gross margin of 83.3%; Current ratio of 3.72 (healthy short-term liquidity); Debt-to-equity of 0.05; Free cash flow per share is negative (-3.85); Earnings-history trend unavailable; growth based on TTM year-over-year only.
Get the Full INSM Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →